Same Indication

Nystatin vs Pembrolizumab

Nystatin vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between Nystatin and Pembrolizumab.

Mechanism of Action

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Pembrolizumab β€” 26 days.

Chemical Properties

Type: Nystatin β€” Unknown; Pembrolizumab β€” Antibody.